Holdings (Monthly)
Guide ↗
Global X Genomics & Biotechnology ETF
· Global X Funds| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | MODERNA, INC. | 60770K107 | Feb 2026 | 76,841 | $4.1M | 7.86% | EC |
| 2 | Praxis Precision Medicines Inc | 74006W207 | Feb 2026 | 9,697 | $3.3M | 6.23% | EC |
| 3 | ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | Feb 2026 | 47,107 | $3.0M | 5.69% | EC |
| 4 | ILLUMINA, INC. | 452327109 | Feb 2026 | 19,973 | $2.7M | 5.13% | EC |
| 5 | GUARDANT HEALTH, INC. | 40131M109 | Feb 2026 | 26,261 | $2.5M | 4.71% | EC |
| 6 | VERTEX PHARMACEUTICALS INCORPORATED | 92532F100 | Feb 2026 | 4,551 | $2.3M | 4.32% | EC |
| 7 | BIOMARIN PHARMACEUTICAL INC. | 09061G101 | Feb 2026 | 36,598 | $2.3M | 4.31% | EC |
| 8 | NATERA, INC. | 632307104 | Feb 2026 | 9,843 | $2.0M | 3.91% | EC |
| 9 | BioNTech SE | 09075V102 | Feb 2026 | 18,367 | $2.0M | 3.87% | EC |
| 10 | Avidity Biosciences Inc | 05370A108 | Feb 2026 | 27,249 | $2.0M | 3.75% | EC |
| 11 | Qiagen N.V. | N72482156 | Feb 2026 | 38,211 | $1.9M | 3.63% | EC |
| 12 | CRISPR Therapeutics AG | H17182108 | Feb 2026 | 30,338 | $1.8M | 3.48% | EC |
| 13 | BIO-TECHNE CORPORATION | 09073M104 | Feb 2026 | 30,603 | $1.8M | 3.45% | EC |
| 14 | BRISTOL-MYERS SQUIBB COMPANY | 110122108 | Feb 2026 | 22,278 | $1.4M | 2.65% | EC |
| 15 | ALNYLAM PHARMACEUTICALS, INC. | 02043Q107 | Feb 2026 | 3,941 | $1.3M | 2.51% | EC |
| 16 | BNYREPOS | BNYREPOS | Feb 2026 | 1,252,576 | $1.3M | 2.39% | RA |
| 17 | Veracyte Inc | 92337F107 | Feb 2026 | 34,212 | $1.3M | 2.39% | EC |
| 18 | ELI LILLY AND COMPANY | 532457108 | Feb 2026 | 1,165 | $1.2M | 2.34% | EC |
| 19 | Twist Bioscience Corp | 90184D100 | Feb 2026 | 25,637 | $1.2M | 2.30% | EC |
| 20 | GILEAD SCIENCES, INC. | 375558103 | Feb 2026 | 8,009 | $1.2M | 2.28% | EC |
| 21 | ASTRAZENECA PLC | N/A | Feb 2026 | 5,706 | $1.2M | 2.28% | EC |
| 22 | Beam Therapeutics Inc | 07373V105 | Feb 2026 | 40,627 | $1.2M | 2.21% | EC |
| 23 | 10X Genomics Inc | 88025U109 | Feb 2026 | 49,124 | $1.1M | 2.16% | EC |
| 24 | Legend Biotech Corp | 52490G102 | Feb 2026 | 59,071 | $1.1M | 2.14% | EC |
| 25 | Ultragenyx Pharmaceutical Inc | 90400D108 | Feb 2026 | 39,779 | $930K | 1.78% | EC |
| 26 | GeneDx Holdings Corp | 81663L200 | Feb 2026 | 11,270 | $898K | 1.72% | EC |
| 27 | WAVE Life Sciences Ltd | Y95308105 | Feb 2026 | 56,445 | $786K | 1.50% | EC |
| 28 | Genscript Biotech Corp | N/A | Feb 2026 | 498,918 | $762K | 1.45% | EC |
| 29 | SAREPTA THERAPEUTICS, INC. | 803607100 | Feb 2026 | 40,976 | $687K | 1.31% | EC |
| 30 | INTELLIA THERAPEUTICS, INC. | 45826J105 | Feb 2026 | 45,069 | $621K | 1.19% | EC |
| 31 | CAREDX, INC. | 14167L103 | Feb 2026 | 22,308 | $418K | 0.80% | EC |
| 32 | Uniqure NV | N90064101 | Feb 2026 | 24,242 | $379K | 0.72% | EC |
| 33 | Vir Biotechnology Inc | 92764N102 | Feb 2026 | 40,138 | $365K | 0.70% | EC |
| 34 | Personalis Inc | 71535D106 | Feb 2026 | 23,562 | $213K | 0.41% | EC |
| 35 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 69404D108 | Feb 2026 | 119,496 | $201K | 0.38% | EC |
| 36 | AGILENT TECHNOLOGIES, INC. | 00846U101 | Feb 2026 | 1,653 | $201K | 0.38% | EC |
| 37 | ROCKET PHARMACEUTICALS, INC. | 77313F106 | Feb 2026 | 37,567 | $188K | 0.36% | EC |
| 38 | Prime Medicine Inc | 74168J101 | Feb 2026 | 40,671 | $188K | 0.36% | EC |
| 39 | Regenxbio Inc | 75901B107 | Feb 2026 | 20,483 | $185K | 0.35% | EC |
| 40 | MYRIAD GENETICS, INC. | 62855J104 | Feb 2026 | 39,242 | $181K | 0.35% | EC |
| 41 | MESA LABORATORIES, INC. | 59064R109 | Feb 2026 | 1,851 | $179K | 0.34% | EC |
| 42 | Maravai LifeSciences Holdings Inc | 56600D107 | Feb 2026 | 46,674 | $166K | 0.32% | EC |
| 43 | Stoke Therapeutics Inc | 86150R107 | Feb 2026 | 4,522 | $165K | 0.31% | EC |
| 44 | STANDARD BIOTOOLS INC. | 34385P108 | Feb 2026 | 119,323 | $135K | 0.26% | EC |
| 45 | FULGENT GENETICS, INC. | 359664109 | Feb 2026 | 8,763 | $134K | 0.26% | EC |
| 46 | Arcturus Therapeutics Holdings Inc | 03969T109 | Feb 2026 | 15,040 | $124K | 0.24% | EC |
| 47 | Caribou Biosciences Inc | 142038108 | Feb 2026 | 59,913 | $114K | 0.22% | EC |
| 48 | Sana Biotechnology Inc | 799566104 | Feb 2026 | 26,441 | $111K | 0.21% | EC |
| 49 | SANGAMO THERAPEUTICS, INC. | 800677106 | Feb 2026 | 244,820 | $106K | 0.20% | EC |
| 50 | EDITAS MEDICINE, INC. | 28106W103 | Feb 2026 | 46,709 | $103K | 0.20% | EC |
| 51 | Atrium Therapeutics Inc | 04965N104 | Feb 2026 | 2,725 | $40K | 0.08% | EC |